Kalaris Therapeutics, Inc. (KLRS): SCHEDULE 13D/A filed Dec 22, 2025

Form type

SCHEDULE 13D/A

Filing date

Dec 22, 2025

Accession number

0001699737-25-000032

Filer

Kalaris Therapeutics, Inc. (CIK 1754068)